Health Savings Freedom Act of 2022
A BILL
To amend the Internal Revenue Code of 1986 to raise the limit on contributions to health savings accounts, to remove the requirement to maintain high deductible coverage with respect to such accounts, to include drugs and medicine as qualified medical expenses for the purposes of such accounts, and for other purposes.
Sec. 2 Health savings accounts
“(1) Eligible individual
“(A) In general—The term “eligible individual” means, with respect to any month, any individual if such individual is covered under any health plan as of the 1st day of such month.
“(B) Special rule for individuals eligible for certain veterans benefits—An individual shall not fail to be treated as an eligible individual for any period merely because the individual receives hospital care or medical services under any law administered by the Secretary of Veterans Affairs for a service-connected disability (within the meaning of section 101(16) of title 38, United States Code).
“(C) Special rule for individuals receiving benefits subject to surprise billing statutes—An individual shall not fail to be treated as an eligible individual for any period merely because the individual receives benefits for medical care subject to and in accordance with section 9816 or 9817, section 2799A–1 or 2799A–2 of the Public Health Service Act, or section 716 or 717 of the Employee Retirement Income Security Act of 1974, or any State law providing similar protections to such individual.”
“(2) Qualified medical expenses—The term “qualified medical expenses” means the following:
“(A) With respect to an account beneficiary, amounts paid by such beneficiary for any of the following for such individual, the spouse of such individual, any dependent (as defined in section 152, determined without regard to subsections (b)(1), (b)(2), and (d)(1)(B) thereof), or of such individual, but only to the extent such amounts are not compensated for by insurance or otherwise:
“(i) Medical care (as defined in section 213(d)).
“(ii) Medicine and drugs.
“(iii) A tampon, pad, liner, cup, sponge, or similar product used by individuals with respect to menstruation or other genital-tract secretions.
“(B) With respect to an account beneficiary, amounts paid by such beneficiary for long-term care expenses for a parent of such individual, but only to the extent such amounts are not compensated for by insurance or otherwise.”